Home / Universe Pharmaceuticals INC (UPC)

Universe Pharmaceuticals INC (UPC) Technical Analysis

Updated: 2026-05-01 03:14 UTC · Last close: 3.23 (-0.02%) · Support: 3.10 · Resistance: 4.78
Universe Pharmaceuticals INC (UPC) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
3.10
⬆️ Resistance
4.78
⚠️ Risk Line
losing 3.10 would weaken the current structure.
Quick Read
The next meaningful technical decision is likely to occur between support at 3.10 and resistance at 4.78.
🔺 Technical Setup
Triangle
asc / bias UP
Compression
21%
RSI(14)
54.9
🎯 Decision Map
The next meaningful technical decision is likely to occur between support at 3.10 and resistance at 4.78. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup. Pattern-based invalidation is near 5.10; losing that area would weaken the active formation considerably.
📊 Technical Summary
The latest close for Universe Pharmaceuticals INC (UPC) came in at 3.23 (-0.02%). The stock is back above its 50-day average but still below the 200-day average, which suggests improving short-term tone within a still-repairing long-term structure. 20-day momentum is notably strong at +18.29%; price is trading in the lower part of its roughly 52-week range (2.25–9.46); and ATR14 volatility is elevated at roughly 9.20% of price. RSI(14) stands around 54.9, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Near-term structure is defined by support at 3.10 and resistance at 4.78. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 12.88M · Net income: -13.10M · EPS (basic): -3.59. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.
💼 Fundamentals Snapshot
Source: sec
Company
Universe Pharmaceuticals INC
CIK (SEC ID)
0001809616
Shares Out.
3.65M
Revenue
12.88M
Net Income
-13.10M
EPS (Basic)
-3.59
Explore more
Mastercard (MA) technical analysisEli Lilly And Company (LLY) technical analysisUnitedHealth Group (UNH) technical analysisExxon Mobil (XOM) technical analysisCostco Wholesale Corp /New (COST) technical analysisThe Home Depot (HD) technical analysisProcter & Gamble Co (PG) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
UPC Chart